Literature DB >> 16251415

Bacillus anthracis edema toxin causes extensive tissue lesions and rapid lethality in mice.

Aaron M Firoved1, Georgina F Miller, Mahtab Moayeri, Rahul Kakkar, Yuequan Shen, Jason F Wiggins, Elizabeth M McNally, Wei-Jen Tang, Stephen H Leppla.   

Abstract

Bacillus anthracis edema toxin (ET), an adenylyl cyclase, is an important virulence factor that contributes to anthrax disease. The role of ET in anthrax pathogenesis is, however, poorly understood. Previous studies using crude toxin preparations associated ET with subcutaneous edema, and ET-deficient strains of B. anthracis showed a reduction in virulence. We report the first comprehensive study of ET-induced pathology in an animal model. Highly purified ET caused death in BALB/cJ mice at lower doses and more rapidly than previously seen with the other major B. anthracis virulence factor, lethal toxin. Observations of gross pathology showed intestinal intralumenal fluid accumulation followed by focal hemorrhaging of the ileum and adrenal glands. Histopathological analyses of timed tissue harvests revealed lesions in several tissues including adrenal glands, lymphoid organs, bone, bone marrow, gastrointestinal mucosa, heart, and kidneys. Concomitant blood chemistry analyses supported the induction of tissue damage. Several cytokines increased after ET administration, including granulocyte colony-stimulating factor, eotaxin, keratinocyte-derived cytokine, MCP-1/JE, interleukin-6, interleukin-10, and interleukin-1beta. Physiological measurements also revealed a concurrent hypotension and bradycardia. These studies detail the extensive pathological lesions caused by ET and suggest that it causes death due to multiorgan failure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16251415      PMCID: PMC1603774          DOI: 10.1016/S0002-9440(10)61218-7

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  Cushing, cortisol, and cardiovascular disease.

Authors:  J A Whitworth; G J Mangos; J J Kelly
Journal:  Hypertension       Date:  2000-11       Impact factor: 10.190

Review 2.  Nontraditional aspects of aldosterone physiology.

Authors:  C Ngarmukos; R J Grekin
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-12       Impact factor: 4.310

3.  Inferior vena cava thrombosis: a mechanism of posttraumatic adrenal hemorrhage.

Authors:  C R Hinrichs; A Singer; P Maldjian; H Abu-Judeh; A Dadarwala
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

Review 4.  Chemokines in cutaneous wound healing.

Authors:  R Gillitzer; M Goebeler
Journal:  J Leukoc Biol       Date:  2001-04       Impact factor: 4.962

5.  Quantitative pathology of inhalational anthrax I: quantitative microscopic findings.

Authors:  L M Grinberg; F A Abramova; O V Yampolskaya; D H Walker; J H Smith
Journal:  Mod Pathol       Date:  2001-05       Impact factor: 7.842

6.  Structural basis for the activation of anthrax adenylyl cyclase exotoxin by calmodulin.

Authors:  Chester L Drum; Shui-Zhong Yan; Joel Bard; Yue-Quan Shen; Dan Lu; Sandriyana Soelaiman; Zenon Grabarek; Andrew Bohm; Wei-Jen Tang
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

7.  Susceptibility of mitogen-activated protein kinase kinase family members to proteolysis by anthrax lethal factor.

Authors:  G Vitale; L Bernardi; G Napolitani; M Mock; C Montecucco
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

Review 8.  Inhalational anthrax: epidemiology, diagnosis, and management.

Authors:  S Shafazand; R Doyle; S Ruoss; A Weinacker; T A Raffin
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 9.  Anthrax toxins.

Authors:  M Mourez
Journal:  Rev Physiol Biochem Pharmacol       Date:  2004-07-27       Impact factor: 5.545

10.  Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States.

Authors:  J A Jernigan; D S Stephens; D A Ashford; C Omenaca; M S Topiel; M Galbraith; M Tapper; T L Fisk; S Zaki; T Popovic; R F Meyer; C P Quinn; S A Harper; S K Fridkin; J J Sejvar; C W Shepard; M McConnell; J Guarner; W J Shieh; J M Malecki; J L Gerberding; J M Hughes; B A Perkins
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

View more
  104 in total

1.  Select human anthrax protective antigen epitope-specific antibodies provide protection from lethal toxin challenge.

Authors:  Sherry R Crowe; Linda L Ash; Renata J M Engler; Jimmy D Ballard; John B Harley; A Darise Farris; Judith A James
Journal:  J Infect Dis       Date:  2010-07-15       Impact factor: 5.226

Review 2.  New insights into the biological effects of anthrax toxins: linking cellular to organismal responses.

Authors:  Annabel Guichard; Victor Nizet; Ethan Bier
Journal:  Microbes Infect       Date:  2011-09-08       Impact factor: 2.700

3.  Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.

Authors:  Celia M Ebrahimi; Tamsin R Sheen; Christian W Renken; Roberta A Gottlieb; Kelly S Doran
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

4.  Anthrax toxin targeting of myeloid cells through the CMG2 receptor is essential for establishment of Bacillus anthracis infections in mice.

Authors:  Shihui Liu; Sharmina Miller-Randolph; Devorah Crown; Mahtab Moayeri; Inka Sastalla; Shu Okugawa; Stephen H Leppla
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

Review 5.  Anthrax lethal and edema toxins in anthrax pathogenesis.

Authors:  Shihui Liu; Mahtab Moayeri; Stephen H Leppla
Journal:  Trends Microbiol       Date:  2014-03-27       Impact factor: 17.079

6.  Key tissue targets responsible for anthrax-toxin-induced lethality.

Authors:  Shihui Liu; Yi Zhang; Mahtab Moayeri; Jie Liu; Devorah Crown; Rasem J Fattah; Alexander N Wein; Zu-Xi Yu; Toren Finkel; Stephen H Leppla
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

7.  Anthrax vaccination induced anti-lethal factor IgG: fine specificity and neutralizing capacity.

Authors:  Sherry R Crowe; Lori Garman; Renata J M Engler; A Darise Farris; Jimmy D Ballard; John B Harley; Judith A James
Journal:  Vaccine       Date:  2011-03-21       Impact factor: 3.641

8.  Clostridium sordellii lethal toxin kills mice by inducing a major increase in lung vascular permeability.

Authors:  Blandine Geny; Huot Khun; Catherine Fitting; Leticia Zarantonelli; Christelle Mazuet; Nadège Cayet; Marek Szatanik; Marie-Christine Prevost; Jean-Marc Cavaillon; Michel Huerre; Michel R Popoff
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

9.  Histopathology in a murine model of anthrax.

Authors:  Scott Duong; Lucius Chiaraviglio; James E Kirby
Journal:  Int J Exp Pathol       Date:  2006-04       Impact factor: 1.925

10.  B. anthracis edema toxin increases cAMP levels and inhibits phenylephrine-stimulated contraction in a rat aortic ring model.

Authors:  Yan Li; Xizhong Cui; Steven B Solomon; Kenneth Remy; Yvonne Fitz; Peter Q Eichacker
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-04-12       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.